We are thrilled to announce our participation to BioJapan this year!

Due to the global Covid-19 pandemic and unability to travel,SynapCell has put Japan as a top priority of its development and has been building strong relationships with japanese pharmaceutical companies since 2005. We are striving to provide more japanese companies with the opportunity to better address R&D costs and fight the burden of brain diseases with SynapCell by their side.

Let’s e-meet on BioJapan platform!